Watermark
  Back to Search Results

BGB-A317-305

Completed

Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-305

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT03777657

EudraCT Number Info icon SVG graphic used for tooltips or additional information.

2018-000312-24

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20181841

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan